These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38035735)

  • 41. COVID-19 in conflict region: the arab levant response.
    Bizri NA; Alam W; Mobayed T; Tamim H; Makki M; Mushrrafieh U
    BMC Public Health; 2021 Aug; 21(1):1590. PubMed ID: 34445976
    [TBL] [Abstract][Full Text] [Related]  

  • 42. What factors affect evidence-informed policymaking in public health? Protocol for a systematic review of qualitative evidence using thematic synthesis.
    Verboom B; Montgomery P; Bennett S
    Syst Rev; 2016 Apr; 5():61. PubMed ID: 27080993
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Coordinating the research response to COVID-19: Mali's approach.
    Doumbia S; Sow Y; Diakite M; Lau CY
    Health Res Policy Syst; 2020 Sep; 18(1):105. PubMed ID: 32943078
    [TBL] [Abstract][Full Text] [Related]  

  • 44. "Developing good taste in evidence": facilitators of and hindrances to evidence-informed health policymaking in state government.
    Jewell CJ; Bero LA
    Milbank Q; 2008 Jun; 86(2):177-208. PubMed ID: 18522611
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Economic arguments in migrant health policymaking: proposing a research agenda.
    Gottlieb N; Trummer U; Davidovitch N; Krasnik A; Juárez SP; Rostila M; Biddle L; Bozorgmehr K
    Global Health; 2020 Nov; 16(1):113. PubMed ID: 33218359
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Institutional roles, structures, funding and research partnerships towards evidence-informed policy-making: a multisector survey among policy-makers in Nigeria.
    Uneke CJ; Okedo-Alex IN; Akamike IC; Uneke BI; Eze II; Chukwu OE; Otubo KI; Urochukwu HC
    Health Res Policy Syst; 2023 May; 21(1):36. PubMed ID: 37237324
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 'Toothless'-the absence of political priority for oral health: a case study of Ireland 1994-2021.
    McAuliffe Ú; Whelton H; Harding M; Burke S
    BMC Oral Health; 2022 Mar; 22(1):95. PubMed ID: 35346151
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Populations' Resilience Toward the Policymaking Discrepancies in the Pandemic Covid-19 Period.
    Alsaqqa HH
    Front Public Health; 2021; 9():733519. PubMed ID: 34712638
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evidence based policy making and the 'art' of commissioning - how English healthcare commissioners access and use information and academic research in 'real life' decision-making: an empirical qualitative study.
    Wye L; Brangan E; Cameron A; Gabbay J; Klein JH; Pope C
    BMC Health Serv Res; 2015 Sep; 15():430. PubMed ID: 26416368
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Role of Intersectoral Action in Response to COVID-19: A Qualitative Study of the Roles of Academia and the Private Sector in Colombia.
    Turner S; Ulloa AM; Niño N; Valencia Godoy V
    Int J Health Policy Manag; 2022 Sep; 11(9):1913-1925. PubMed ID: 34523858
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Utilization of research findings for health policy making and practice: evidence from three case studies in Bangladesh.
    Walugembe DR; Kiwanuka SN; Matovu JK; Rutebemberwa E; Reichenbach L
    Health Res Policy Syst; 2015 May; 13():26. PubMed ID: 26016797
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Engaging stakeholders to identify gaps and develop strategies to inform evidence use for health policymaking in Nigeria.
    Eboreime E; Ogwa O; Nnabude R; Aluka-Omitiran K; Banke-Thomas A; Orji N; Eluwa A; Ezeokoli A; Rotimi A; Eze LU; Offiong V; Odu U; Okonkwo R; Umeh C; Ilika F; Oreh A; Adams FN; Okpani IA; Ogundeji Y; Mbachu C; Obi FA; Badejo O
    Pan Afr Med J; 2022; 43():140. PubMed ID: 36762150
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lessons learnt from the COVID-19 pandemic in selected countries to inform strengthening of public health systems: a qualitative study.
    Cardwell K; Clyne B; Broderick N; Tyner B; Masukume G; Larkin L; McManus L; Carrigan M; Sharp M; Smith SM; Harrington P; Connolly M; Ryan M; O'Neill M
    Public Health; 2023 Dec; 225():343-352. PubMed ID: 37979311
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An integrated knowledge translation (iKT) approach to advancing community-based depression care in Vietnam: lessons from an ongoing research-policy collaboration.
    Murphy JK; Chau LW; Nguyen VC; Minas H; Anh DV; O'Neil J
    BMC Health Serv Res; 2024 Jan; 24(1):142. PubMed ID: 38279141
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Individual and institutional capacity-building for evidence-informed health policy-making in Iran: a mix of local and global evidence.
    Doshmangir L; Mostafavi H; Behzadifar M; Yazdizadeh B; Sajadi HS; Hasanpoor E; Mahdavi M; Majdzadeh R
    Health Res Policy Syst; 2022 Feb; 20(1):18. PubMed ID: 35151312
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Paper 1: Demand-driven rapid reviews for health policy and systems decision-making: lessons from Lebanon, Ethiopia, and South Africa on researchers and policymakers' experiences.
    Mijumbi-Deve RM; Kawooya I; Kayongo E; Izizinga R; Mamuye H; Amog K; Langlois EV
    Syst Rev; 2022 Jul; 11(1):154. PubMed ID: 35907879
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A retrospective health policy analysis of the development and implementation of the voluntary health insurance system in Lebanon: learning from failure.
    El-Jardali F; Bou-Karroum L; Ataya N; El-Ghali HA; Hammoud R
    Soc Sci Med; 2014 Dec; 123():45-54. PubMed ID: 25462604
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lessons from co-production of evidence and policy in Nigeria's COVID-19 response.
    Abubakar I; Dalglish SL; Ihekweazu CA; Bolu O; Aliyu SH
    BMJ Glob Health; 2021 Mar; 6(3):. PubMed ID: 33741561
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evidence-based policymaking: Lessons from the Chilean Substance Use Treatment Policy.
    Mateo Pinones M; González-Santa Cruz A; Portilla Huidobro R; Castillo-Carniglia A
    Int J Drug Policy; 2022 Nov; 109():103860. PubMed ID: 36206612
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Perspectives on the production, and use, of rapid evidence in decision making during the COVID-19 pandemic: a qualitative study.
    Clyne B; Hynes L; Kirwan C; McGeehan M; Byrne P; Killilea M; Smith SM; Ryan M; Collins C; O'Neill M; Wallace E; Murphy AW; Kelly ME
    BMJ Evid Based Med; 2023 Feb; 28(1):48-57. PubMed ID: 35772940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.